Growth Metrics

Edwards Lifesciences (EW) Other Non-Current Assets (2016 - 2025)

Edwards Lifesciences has reported Other Non-Current Assets over the past 17 years, most recently at $784.8 million for Q3 2025.

  • Quarterly results put Other Non-Current Assets at $784.8 million for Q3 2025, up 14.82% from a year ago — trailing twelve months through Sep 2025 was $784.8 million (up 14.82% YoY), and the annual figure for FY2024 was $10.8 million, down 97.67%.
  • Other Non-Current Assets for Q3 2025 was $784.8 million at Edwards Lifesciences, up from $12.8 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for EW hit a ceiling of $784.8 million in Q3 2025 and a floor of $10.8 million in Q4 2024.
  • Median Other Non-Current Assets over the past 5 years was $293.6 million (2023), compared with a mean of $297.4 million.
  • Biggest five-year swings in Other Non-Current Assets: surged 169.95% in 2022 and later plummeted 98.38% in 2025.
  • Edwards Lifesciences' Other Non-Current Assets stood at $110.8 million in 2021, then skyrocketed by 169.95% to $299.1 million in 2022, then skyrocketed by 54.86% to $463.2 million in 2023, then tumbled by 97.67% to $10.8 million in 2024, then surged by 7166.67% to $784.8 million in 2025.
  • The last three reported values for Other Non-Current Assets were $784.8 million (Q3 2025), $12.8 million (Q2 2025), and $12.4 million (Q1 2025) per Business Quant data.